share_log

九洲药业(603456.SH):奥卡西平片获得药品注册证书

Zhejiang Jiuzhou Pharmaceutical (603456.SH): Okasipin tablets obtained pharmaceutical registration certificate.

Gelonghui Finance ·  Jul 8 04:27

Zhejiang Jiuzhou Pharmaceutical (603456.SH) announced that its controlling subsidiary, Zhejiang Jiuzhou Biomedical Pharmaceutical Co., Ltd., has received the Drug Registration Certificate for Oxcarbazepine Tablets issued by the National Medical Products Administration. Oxcarbazepine tablets are used to treat primary generalized tonic-clonic seizures and partial seizures with or without secondary generalized seizures.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment